Metrics as of 10/13/2026, 06:33 PM (Berlin time), refresh in progress.
Kneat.com, Inc.
Kneat.com, Inc. develops and provides specialized software solutions for managing data and documents within highly regulated industries across the United States, Ireland, Canada, and other international markets. Its flagship product, the Kneat Gx platform, is a customizable, ready-to-use application designed to…
1D
+0.0%
1W
+0.2%
1M
+0.6%
6M
+58.5%
YTD
+32.1%
1Y
+13.0%
2Y
+40.1%
5Y
+82.6%
10Y
–
Next earnings date
11/11/2026 (in 25 days)
Volatility around earnings
~8% stronger price swings than usual
P/E
-73.61
P/B
9.87
EV/EBITDA
50.67
RETURN ON EQUITY
-6.3%
NET MARGIN
-21.9%
DEBT/EQUITY
0.42
DIVIDEND YIELD
0.0%
AS OF
31/03/2026
FREE FLOAT
78.0%
FLOAT SHARES
75,008,224
AVG. DAILY VOLUME (30D)
198,989
Kneat.com, Inc. is a company in the Healthcare sector, Medical - Healthcare Information Services industry, headquartered in Ireland.
The CEO is Edmund Ryan, the company employs around 343 people.
The IPO was on 01/03/2017; the stock trades on TSX under the ticker KSI.TO.
The next earnings date is 11/11/2026.
Around past earnings, price swings were roughly 8% stronger than usual.
No, Kneat.com currently does not pay a dividend.
Comparable stocks include Hinge Health, HealthEquity, Heartflow, Omada Health, Teladoc Health, SOPHiA GENETICS, Evolent Health and Optima Health.
Clicking "Analyze stock" lets five strategies assess Kneat.com against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.